Literature DB >> 31944916

Fueling Cardiac Hypertrophy.

Timothy R Matsuura1, Teresa C Leone1, Daniel P Kelly1.   

Abstract

Entities:  

Keywords:  Editorials; glycolysis; heart failure; hypertrophy; metabolism; metabolomics

Mesh：

Substances：

Year:  2020        PMID： 31944916      PMCID： PMC7008779          DOI： 10.1161/CIRCRESAHA.119.316358

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  11 in total

1.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus.

Authors:  P J RANDLE; P B GARLAND; C N HALES; E A NEWSHOLME
Journal:  Lancet       Date:  1963-04-13       Impact factor: 79.321

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

3.  Effects of moderate hypertension on cardiac function and metabolism in the rabbit.

Authors:  H Taegtmeyer; M L Overturf
Journal:  Hypertension       Date:  1988-05       Impact factor: 10.190

Review 4.  Myocardial substrate metabolism in the normal and failing heart.

Authors:  William C Stanley; Fabio A Recchia; Gary D Lopaschuk
Journal:  Physiol Rev       Date:  2005-07       Impact factor: 37.312

5.  Cardiac-specific deletion of acetyl CoA carboxylase 2 prevents metabolic remodeling during pressure-overload hypertrophy.

Authors:  Stephen C Kolwicz; David P Olson; Luke C Marney; Lorena Garcia-Menendez; Robert E Synovec; Rong Tian
Journal:  Circ Res       Date:  2012-06-22       Impact factor: 17.367

6.  Inherited cardiomyopathies.

Authors:  D P Kelly; A W Strauss
Journal:  N Engl J Med       Date:  1994-03-31       Impact factor: 91.245

7.  Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth.

Authors:  P M Barger; J M Brandt; T C Leone; C J Weinheimer; D P Kelly
Journal:  J Clin Invest       Date:  2000-06       Impact factor: 14.808

8.  Fatty acid oxidation enzyme gene expression is downregulated in the failing heart.

Authors:  M N Sack; T A Rader; S Park; J Bastin; S A McCune; D P Kelly
Journal:  Circulation       Date:  1996-12-01       Impact factor: 29.690

9.  Substrate-enzyme competition attenuates upregulated anaplerotic flux through malic enzyme in hypertrophied rat heart and restores triacylglyceride content: attenuating upregulated anaplerosis in hypertrophy.

Authors:  Kayla M Pound; Natalia Sorokina; Kalpana Ballal; Deborah A Berkich; Mathew Fasano; Kathryn F Lanoue; Heinrich Taegtmeyer; J Michael O'Donnell; E Douglas Lewandowski
Journal:  Circ Res       Date:  2009-02-12       Impact factor: 17.367

10.  The failing heart utilizes 3-hydroxybutyrate as a metabolic stress defense.

Authors:  Julie L Horton; Michael T Davidson; Clara Kurishima; Rick B Vega; Jeffery C Powers; Timothy R Matsuura; Christopher Petucci; E Douglas Lewandowski; Peter A Crawford; Deborah M Muoio; Fabio A Recchia; Daniel P Kelly
Journal:  JCI Insight       Date:  2019-02-21
View more
  2 in total

1.  Wnt-C59 Attenuates Pressure Overload-Induced Cardiac Hypertrophy via Interruption of Wnt Pathway.

Authors:  Zhengbo Zhao; Han Liu; Yu Li; Jingxiu Tian; Songbai Deng
Journal:  Med Sci Monit       Date:  2020-04-12

2.  YAP mediates compensatory cardiac hypertrophy through aerobic glycolysis in response to pressure overload.

Authors:  Toshihide Kashihara; Risa Mukai; Shin-Ichi Oka; Peiyong Zhai; Yasuki Nakada; Zhi Yang; Wataru Mizushima; Tsutomu Nakahara; Junco S Warren; Maha Abdellatif; Junichi Sadoshima
Journal:  J Clin Invest       Date:  2022-03-15       Impact factor: 14.808
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.